The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways
Open accessAbstract
MEF2C haploinsufficiency syndrome is an emerging neurodevelopmental disorder associated with intellectual disability, autistic features, epilepsy, and abnormal movements. We report 16 new patients with MEF2C haploinsufficiency, including the oldest reported patient with MEF2C deletion at 5q14.3. We detail the neurobehavioral phenotype, epilepsy, and abnormal movements, and compare our subjects with those previously reported in the literature. We also investigate Mef2c expression in the developing mouse forebrain. A spectrum of neurofunctional deficits emerges, with hyperkinesis a consistent finding. Epilepsy varied from absent to severe, and included intractable myoclonic seizures and infantile spasms. Subjects with partial MEF2C deletion were statistically less likely to have epilepsy. Finally, we confirm that Mef2c is present both in dorsal primary neuroblasts and ventral gamma-aminobutyric acid(GABA)ergic interneurons in the forebrain of the developing mouse. Given interactions with several key neurodevelopmental genes such as ARX, FMR1, MECP2, and TBR1, it appears that MEF2C plays a role in several developmental stages of both dorsal and ventral neuronal cell types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the MEF2 splicing factor ataxin-2-binding protein 1 (A2BP1; also known as RBFOX1) — previously implicated in ASD203,204 — was identified as a central hub within the network of downregulated genes associated with synaptic function.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [203]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
Rett syndrome: Revised diagnostic criteria and nomenclature
Neul, J. L., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke, A. J., Bahi‐Buisson, N., Leonard, H., Bailey, M. E. S., Schanen, N. C., Zappella, M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22124 · Cited by 1,437
MEF2: a central regulator of diverse developmental programs
Potthoff, M. J., & Olson, E. N. (2007) · Development · doi:10.1242/dev.008367 · Cited by 834
Definition and classification of hyperkinetic movements in childhood
Sanger, T. D., Chen, D., Fehlings, D. L., Hallett, M., Lang, A. E., Mink, J. W., Singer, H. S., Alter, K. E., Ben‐Pazi, H., Butler, E. E., et al. (2010) · Movement Disorders · doi:10.1002/mds.23088 · Cited by 465
Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex
Bedogni, F., Hodge, R. D., Elsen, G. E., Nelson, B. R., Daza, R. A. M., Beyer, R. P., Bammler, T. K., Rubenstein, J. L. R., & Hevner, R. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002285107 · Cited by 322
Barbosa, A. C., Kim, M.-S., Ertunc, M., Adachi, M., Nelson, E. D., McAnally, J., Richardson, J. A., Kavalali, E. T., Monteggia, L. M., Bassel-Duby, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802679105 · Cited by 303
Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation
Lyons, G., Micales, B. K., Schwarz, J. J., Martin, J., & Olson, E. N. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05727.1995 · Cited by 271
Li, H., Radford, J. C., Ragusa, M. J., Shea, K. L., McKercher, S. R., Zaremba, J. D., Soussou, W., Nie, Z., Kang, Y., Nakanishi, N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802876105 · Cited by 263
Kortüm, F., Das, S., Flindt, M., Morris-Rosendahl, D. J., Stefanova, I., Goldstein, A. C., Horn, D., Klopocki, E., Kluger, G. J., Martin, P., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.087528 · Cited by 243
Self-citationMeur, N. L., Holder‐Espinasse, M., Jaillard, S., Goldenberg, A., Joriot, S., Amati‐Bonneau, P., Guichet, A., Barth, M., Charollais, A., Journel, H., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.069732 · Cited by 228
Cited by
Sorted by citations
Hyde, C. L., Nagle, M. W., Tian, C., Chen, X., Paciga, S. A., Wendland, J. R., Tung, J. Y., Hinds, D. A., Perlis, R. H., & Winslow, A. R. (2016) · Nature Genetics · doi:10.1038/ng.3623 · Cited by 784
Coe, B. P., Witherspoon, K., Rosenfeld, J. A., van Bon, B. W. M., Vulto-van Silfhout, A. T., Bosco, P., Friend, K. L., Baker, C., Buono, S., Vissers, L. E. L. M., et al. (2014) · Nature Genetics · doi:10.1038/ng.3092 · Cited by 720
Self-citationImmune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Mechanisms governing activity-dependent synaptic pruning in the developing mammalian CNS
Faust, T. E., Gunner, G., & Schafer, D. P. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00507-y · Cited by 477
Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity
Coe, B. P., Stessman, H. A. F., Sulovari, A., Geisheker, M. R., Bakken, T. E., Lake, A. M., Dougherty, J. D., Lein, E. S., Hormozdiari, F., Bernier, R. A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0288-4 · Cited by 330
Synaptopathology Involved in Autism Spectrum Disorder
Guang, S., Pang, N., Deng, X., Yang, L., He, F. P., Wu, L., Chen, C., Yin, F., & Peng, J. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00470 · Cited by 298
Advancing epilepsy genetics in the genomic era
Myers, C. T., & Mefford, H. C. (2015) · Genome Medicine · doi:10.1186/s13073-015-0214-7 · Cited by 253
MEF2 transcription factors: developmental regulators and emerging cancer genes
Pon, J. R., & Marra, M. A. (2015) · Oncotarget · doi:10.18632/oncotarget.6223 · Cited by 207
Harrington, A. J., Raissi, A., Rajkovich, K., Berto, S., Kumar, J., Molinaro, G., Raduazzo, J., Guo, Y., Loerwald, K., Konopka, G., et al. (2016) · eLife · doi:10.7554/elife.20059 · Cited by 193
Autism spectrum disorder and epilepsy: Disorders with a shared biology
Lee, B. H., Smith, T., & Paciorkowski, A. R. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.03.017 · Cited by 172
Self-citationIf not Angelman, what is it? a review of Angelman‐like syndromes
Tan, W., Bird, L. M., Thibert, R. L., & Williams, C. A. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36416 · Cited by 128
MeCP2: the long trip from a chromatin protein to neurological disorders
Ausió, J., Paz, A. M. D., & Esteller, M. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.03.004 · Cited by 108
NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
Tu, S., Akhtar, M. W., Escorihuela, R. M., Amador‐Arjona, A., Swarup, V., Parker, J., Zaremba, J. D., Holland, T., Bansal, N., Holohan, D. R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01563-8 · Cited by 104
Copy number variations in cryptogenic cerebral palsy
Segel, R., Ben‐Pazi, H., Zeligson, S., Fatal-Valevski, A., Aran, A. A., Gross‐Tsur, V., Sender, N. S., Shmueli, D., Lev, D., Perlberg, S., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001494 · Cited by 103
Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy
Jiang, X., Lachance, M., & Rossignol, E. (2016) · Progress in brain research · doi:10.1016/bs.pbr.2016.04.012 · Cited by 101
Emerging roles for MEF2 in brain development and mental disorders
Assali, A., Harrington, A. J., & Cowan, C. W. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.04.008 · Cited by 92
Epilepsy and outcome in FOXG1‐related disorders
Seltzer, L. E., Ma, M., Ahmed, S., Bertrand, M. E., Dobyns, W. B., Wheless, J. W., & Paciorkowski, A. R. (2014) · Epilepsia · doi:10.1111/epi.12648 · Cited by 69
Self-citationMolecular characterization of a cohort of 73 patients with infantile spasms syndrome
Boutry‐Kryza, N., Labalme, A., Ville, D. M., de Bellescize, J., Touraine, R. L., Prieur, F., Dimassi, S., Poulat, A., Till, M., Rossi, M., et al. (2014) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2014.11.007 · Cited by 70
Does higher education protect against obesity? Evidence using Mendelian randomization
Böckerman, P., Viinikainen, J., Pulkki-Råbäck, L., Hakulinen, C. A., Pitkänen, N., Lehtimäki, T. J., Pehkonen, J., & Raitakari, O. T. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.06.015 · Cited by 69
Different MicroRNA Profiles in Chronic Epilepsy Versus Acute Seizure Mouse Models
Kretschmann, A., Danis, B., Andonovic, L., Abnaof, K., van Rikxoort, M., Siegel, F., Mazzuferi, M., Godard, P., Hanon, É., Fröhlich, H., et al. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0368-6 · Cited by 67
The expanding spectrum of movement disorders in genetic epilepsies
Papandreou, A., Danti, F. R., Spaull, R., Leuzzi, V., McTague, A., & Kurian, M. A. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14407 · Cited by 65
Harrington, A. J., Bridges, C. M., Berto, S., Blankenship, K., Cho, J. Y., Assali, A., Siemsen, B. M., Moore, H. W., Tsvetkov, E., Thielking, A. M., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.03.011 · Cited by 63
De Novo Mutations in SIK1 Cause a Spectrum of Developmental Epilepsies
Hansen, J. N., Snow, C. J., Tuttle, E. T., Ghoneim, D. H., Yang, C., Spencer, A., Gunter, S. A., Smyser, C. D., Gurnett, C. A., Shinawi, M. S., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.02.013 · Cited by 59
Self-citationThe multiple roles of salt-inducible kinases in regulating physiology
Jagannath, A., Taylor, L., Ru, Y., Wakaf, Z., Akpobaro, K., Vasudevan, S. R., & Foster, F. (2023) · Physiological Reviews · doi:10.1152/physrev.00023.2022 · Cited by 64
MEF2C haploinsufficiency syndrome: Report of a new MEF2C mutation and review
Rocha, H., Sampaio, M., Rocha, R. F., Fernandes, S., & Leão, M. (2016) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2016.05.017 · Cited by 58
Progress on the Roles of MEF2C in Neuropsychiatric Diseases
Zhang, Z., & Zhao, Y. (2022) · Molecular Brain · doi:10.1186/s13041-021-00892-6 · Cited by 56
Molecular profiling of the hippocampus of children with autism spectrum disorder
Rexrode, L., Hartley, J., Showmaker, K. C., Challagundla, L., Vandewege, M. W., Martin, B. E., Blair, E., Bollavarapu, R., Antonyraj, R. B., Hilton, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02441-8 · Cited by 73
Autism spectrum disorder and epileptic encephalopathy: common causes, many questions
Srivastava, S., & Şahin, M. (2017) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-017-9202-0 · Cited by 55
Postnatal Loss of Mef2c Results in Dissociation of Effects on Synapse Number and Learning and Memory
Adachi, M., Lin, P.-Y., Pranav, H., & Monteggia, L. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.018 · Cited by 55
An essential role for MEF2C in the cortical response to loss of sleep in mice
Bjorness, T. E., Kulkarni, A., Rybalchenko, V., Suzuki, A., Bridges, C., Harrington, A. J., Cowan, C. W., Takahashi, J. S., Konopka, G., & Greene, R. W. (2020) · eLife · doi:10.7554/elife.58331 · Cited by 50
ADGRV1 is implicated in myoclonic epilepsy
Myers, K. A., Nasioulas, S., Boys, A., McMahon, J. M., Slater, H. R., Lockhart, P. J., du Sart, D., & Scheffer, I. E. (2017) · Epilepsia · doi:10.1111/epi.13980 · Cited by 51
Vrečar, I., Innes, J., Jones, E. A., Kingston, H. M., Reardon, W., Kerr, B. A., Clayton‐Smith, J., & Douzgou, S. (2017) · Journal of Pediatric Genetics · doi:10.1055/s-0037-1601335 · Cited by 46
The Role of MEF2 Transcription Factor Family in Neuronal Survival and Degeneration
Lisek, M., Przybyszewski, O., Żylińska, L., Guo, F., & Boczek, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043120 · Cited by 48
Patel, A., & Rosenfeld, J. A. (2016) · Journal of Pediatric Genetics · doi:10.1055/s-0036-1584306 · Cited by 46
Self-citationNagar, S., Noveral, S. M., Trudler, D., Lopez, K. M., McKercher, S. R., Han, X., Yates, J. R., Piña-Crespo, J., Nakanishi, N., Satoh, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613067114 · Cited by 44
Mohajeri, K., Yadav, R., D’haene, E., Boone, P. M., Erdin, S., Gao, D., Moysés‐Oliveira, M., Bhavsar, R., Currall, B., O’Keefe, K., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.09.015 · Cited by 30
Pröschel, C., Hansen, J. N., Ali, A. A., Tuttle, E. T., Lacagnina, M., Buscaglia, G., Halterman, M. W., & Paciorkowski, A. R. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.145 · Cited by 32
Self-citationCosgrove, D., Whitton, L., Fahey, L., Broin, P. Ó., Donohoe, G. J., & Morris, D. W. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa213 · Cited by 32
O’Tuathaigh, C. M. P., & Waddington, J. L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.016 · Cited by 31
Modeling epileptic spasms during infancy: Are we heading for the treatment yet?
Velı́šek, L., & Velı́šková, J. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107578 · Cited by 31
Chen, L., Zhou, A. S., & West, A. E. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00067.2017 · Cited by 35
Hollins, S. L., Zavitsanou, K., Walker, F. R., & Cairns, M. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.021 · Cited by 30
Genetics implicate common mechanisms in autism and schizophrenia: synaptic activity and immunity
Liu, X., Li, Z., Fan, C., Zhang, D., & Chen, J. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104487 · Cited by 27
Wang, J., Zhang, Q., Chen, Y., Yu, S., Wu, X., Bao, X., & Wen, Y. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0699-1 · Cited by 27
Borlot, F., Whitney, R., Cohn, R. D., & Weiss, S. K. (2019) · Seizure · doi:10.1016/j.seizure.2019.03.015 · Cited by 27
Dugger, S. A., Dhindsa, R. S., Sampaio, G. L. D. A., Ressler, A. K., Rafikian, E. E., Petri, S., Letts, V. A., Teoh, J. J., Ye, J., Colombo, S., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010952 · Cited by 30
Shimizu, H., Morimoto, Y., Yamamoto, N., Tayama, T., Ozawa, H., & Imamura, A. (2022) · Epilepsy · doi:10.36255/exon-publications-epilepsy-neurodevelopmental-disorders · Cited by 28
Muench, C., Schwandt, M. L., Jung, J., Cortes, C. R., Momenan, R., & Lohoff, F. W. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0184-9 · Cited by 25
MEF-2 isoforms' (A-D) roles in development and tumorigenesis
Madugula, K., Mulherkar, R., Khan, Z. K., Chigbu, D. I., Patel, D., Harhaj, E. W., & Jain, P. (2019) · Oncotarget · doi:10.18632/oncotarget.26763 · Cited by 26
Koopman, C. D., Angelis, J. E. D., Iyer, S. P., Verkerk, A. O., da Silva, J. A., Berecki, G., Jeanes, A., Baillie, G. J., Paterson, S., Uribe, V., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018220118 · Cited by 23
Accounting for cis-regulatory constraint prioritizes genes likely to affect species-specific traits
Starr, A. L., Gokhman, D., & Fraser, H. B. (2023) · Genome biology · doi:10.1186/s13059-023-02846-8 · Cited by 21
Basu, S., Ro, E. J., Liu, Z., Kim, H., Bennett, A., Kang, S., & Suh, H. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1058-23.2023 · Cited by 25
Involvement of myocyte enhancer factor 2c in the pathogenesis of autism spectrum disorder
Chaudhary, R., Agarwal, V., Kaushik, A. S., & Rehman, M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06854 · Cited by 21
Trudler, D., Ghatak, S., Bula, M., Parker, J., Talantova, M. V., Luevanos, M., Labra, S. R., Grabauskas, T., Noveral, S. M., Teranaka, M., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02761-9 · Cited by 24
Genetic investigations of the epileptic encephalopathies
Myers, C. T., & Mefford, H. C. (2016) · Progress in brain research · doi:10.1016/bs.pbr.2016.04.006 · Cited by 22
Coleman, J. A. C., Sarasua, S. M., Boccuto, L., Moore, H. W., Skinner, S. A., & DeLuca, J. M. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62412 · Cited by 20
Epilepsy genetics: The ongoing revolution
Lesca, G., & Depienne, C. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.01.569 · Cited by 19
Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders
Bach, S., Ryan, N., Guasoni, P., Corvin, A. P., El-Nemr, R. A., Khan, D., Sanfeliu, A., & Tropea, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-79268-0 · Cited by 20
Allen, S. J., & Morishita, H. (2024) · Science Advances · doi:10.1126/sciadv.adh3920 · Cited by 13
Function analysis of Mef2c promoter in muscle differentiation
Jin, W., Liu, M., Peng, J., & Jiang, S. (2016) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1524 · Cited by 14
Clinical findings from the landmark MEF2C ‐related disorders natural history study
Coleman, J. A. C., Sarasua, S. M., Moore, H. W., Boccuto, L., Cowan, C. W., Skinner, S. A., & DeLuca, J. M. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1919 · Cited by 13
Tanteles, G. A., Alexandrou, A., Evangelidou, P., Gavatha, M., Anastasiadou, V., & Sismani, C. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36945 · Cited by 13
SIK3 suppresses neuronal hyperexcitability by regulating the glial capacity to buffer K+ and water
Li, H., Russo, A., & DiAntonio, A. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201907138 · Cited by 13
Electroclinical features of MEF2C haploinsufficiency-related epilepsy: A multicenter European study
Raviglione, F., Douzgou, S., Scala, M., Mingarelli, A., D’Arrigo, S., Freri, E., Darra, F., Giglio, S., Bonaglia, M. C., Pantaleoni, C., et al. (2021) · Seizure · doi:10.1016/j.seizure.2021.03.025 · Cited by 12
Komorowski, A., Vidal, R. O., Singh, A., Murgaš, M., Pena‐Centeno, T., Gryglewski, G., Kasper, S., Wiltfang, J., Lanzenberger, R. R., & Goya‐Maldonado, R. (2022) · Human Brain Mapping · doi:10.1002/hbm.26001 · Cited by 12
Genotypes and Phenotypes of MEF2C Haploinsufficiency Syndrome: New Cases and Novel Point Mutations
Wan, L., Liu, X., Hu, L., Chen, H., Sun, Y., Li, Z., Wang, Z., Lin, Z., Zou, L., & Yang, G. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.664449 · Cited by 10
Cho, J. Y., Rumschlag, J. A., Tsvetkov, E., Proper, D. S., Lang, H., Berto, S., Assali, A., & Cowan, C. W. (2024) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2024.100289 · Cited by 10
Yousefian-Jazi, A., Kim, S., Chu, J., Choi, S.-H., Nguyen, P. T.-T., Park, U., Kim, M.-G., Hwang, H., Lee, K., Kim, Y., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00792-y · Cited by 9
The function of Mef2c toward the development of excitatory and inhibitory cortical neurons
Ward, C., Sjulson, L., & Batista‐Brito, R. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1465821 · Cited by 8
Evolution is in the details: Regulatory differences in modern human and Neanderthal
Barker, H. R., Parkkila, S., & Tolvanen, M. E. E. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.052 · Cited by 10
Polymicrogyria and myoclonic epilepsy in autosomal recessive cutis laxa type 2A
Cohen, R., Halevy, A., Aharoni, S., Kraus, D., Konen, O., Basel‐Vanagaite, L., Goldberg‐Stern, H., & Straussberg, R. (2016) · Neurogenetics · doi:10.1007/s10048-016-0491-3 · Cited by 8
Gordon, C. T., Tessier, A., Demir, Z., Goldenberg, A., Oufadem, M., Voisin, N., Pingault, V., Bienvenu, T., Lyonnet, S., de Pontual, L., et al. (2017) · Clinical Genetics · doi:10.1111/cge.13046 · Cited by 8
Dugger, S. A., Dhindsa, R. S., Sampaio, G. L. D. A., Ressler, A. K., Rafikian, E. E., Petri, S., Letts, V. A., Teoh, J. J., Ye, J., Colombo, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.01.072512 · Cited by 8
Tamura, T., Yamamoto, K. S., Imaizumi, T., Yamamoto, H., Miyamoto, Y., Yagasaki, H., Morioka, I., Kanno, H., & Yamamoto, T. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63182 · Cited by 7
Jugular pit associated with 5q14.3 deletion incorporating the MEF2C locus
Al-Shehhi, M., Betts, D. R., Ardle, L. M., Donoghue, V. B., & Reardon, W. (2015) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000102 · Cited by 6
Transcriptional Regulation of Cortical Interneuron Development
Pai, E. L.-L., Vogt, D. L., Hu, J. S., & Rubenstein, J. L. R. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0047 · Cited by 6
Rizzardi, L. F., Hickey, P. F., DiBlasi, V. R., Tryggvadóttir, R., Callahan, C. M., Idrizi, A., Hansen, K. D., & Feinberg, A. P. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/120386 · Cited by 5
Cosgrove, D., Whitton, L., Fahey, L., Broin, P. Ó., Donohoe, G. J., & Morris, D. W. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.16.877837 · Cited by 5
Determinants of renin cell differentiation: a single cell epi-transcriptomics approachPreprint
Martini, A. G., Smith, J. P., Medrano, S., Sheffield, N. C., Sequeira-Lόpez, M. L. S., & Gómez, R. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.18.524595 · Cited by 5
Topic modeling analysis of the Allen Human Brain Atlas
Pizzini, L., Valle, F., Osella, M., & Caselle, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-91079-9 · Cited by 4
Adrião, A., Santana, I. J., Ribeiro, C., Cancela, M. L., Conceição, N., & Grazina, M. M. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05269-0 · Cited by 4
Application of brain organoids in neurodevelopmental disorders
Zhao, C., Qi, Y., Xia, L., Zhu, T., & Xia, K. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152405 · Cited by 3
Rodríguez, J. G., de la Rosa‐Fernández, E., Sarrionandia, I. L., García, E. B., Moyano, M. H., Moreno, H. J. M., & Hernández, J. S. (2024) · Pediatric Dermatology · doi:10.1111/pde.15748 · Cited by 3
Coleman, J. A. C., Sarasua, S. M., Boccuto, L., Moore, H. W., Skinner, S. A., & DeLuca, J. M. (2021) · Nursing Open · doi:10.1002/nop2.840 · Cited by 3
cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsyPreprint
Huang, Y., Fan, L., Wong, M. Y., Lei, Z., Krishnamachary, B., Zhu, D., Cadiz, M. P., Nagiri, R. K., Ye, P., Norman, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.30.702860 · Cited by 3
Identification of an episignature for the MEF2C-associated syndrome
Silva, A., Haghshenas, S., van der Laan, L., Levy, M. A., Relator, R., McConkey, H., Kerkhof, J., Skinner, S. A., Faivre, L. O., Lespinasse, J., et al. (2025) · European Journal of Human Genetics · doi:10.1038/s41431-025-01983-x · Cited by 2
Синдром Ангельмана. Часть 3 (дифференциальная диагностика и лечение)
Абатуров, А. Е., Petrenko, L. L., & Kryvusha, O. L. (2020) · CHILD`S HEALTH · doi:10.22141/2224-0551.7.67.2015.75100 · Cited by 2
Neurodevelopmental disease genes implicated by de novo mutation and CNV morbidityPreprint
Coe, B. P., Stessman, H. A. F., Sulovari, A., Geisheker, M. R., Hormozdiari, F., & Eichler, E. E. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/209908 · Cited by 2
Aberrant gliogenesis and excitation in MEF2C autism patient hiPSC-neurons and cerebral organoidsPreprint
Trudler, D., Ghatak, S., Parker, J., Talantova, M. V., Grabauskas, T., Noveral, S. M., Teranaka, M., Luevanos, M., Dolatabadi, N., Bakker, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.19.387639 · Cited by 2
Microglial MEF2C is a uniquely human bridge between neurodevelopment and neurodegeneration
Rahman, R. J., & Bennett, M. L. (2025) · Nature Immunology · doi:10.1038/s41590-025-02313-5 · Cited by 1
Wang, Y., Jia, Y., Wu, Y., Zhao, Q., Guo, Y., Zhang, L., Jin, M., & Zheng, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-72942-3 · Cited by 1
Tantipongpiradet, A., Davis, R., Altieri, E. A., O'Connor, K. E., & Murphy, K. J. (2026) · Neurobiology of Stress · doi:10.1016/j.ynstr.2026.100824 · Cited by 1
Zhao, X., Xie, Z., He, W., Koh, H. Y., Guo, B., Chen, H., Fornage, M., & Zhi, D. (2026) · Nature Communications · doi:10.1038/s41467-026-73996-z · Cited by 1
MEF2C gene variations are associated with ADHD in the Chinese Han population: a case–control study
Fu, X., Yao, T., Chen, X., Li, H., & Wu, J. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02490-9 · Cited by 2
Harrington, A. J., Bridges, C., Blankenship, K., Assali, A., Berto, S., Siemsen, B. M., Moore, H. W., Cho, J. Y., Tsvetkov, E., Thielking, A. M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/824151 · Cited by 1
Whole-brain in vivo base editing reverses autistic-like behaviors in micePreprint
Li, W., Chen, J., Peng, W., Yuan, B., Han, W., Yuan, Y., Xue, Z., Wang, J., Chen, Z., Shan, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.25.477781 · Cited by 1
Fregoso, S. P., Atapattu, M., Callies, K., Monet, D., Leonardson, A. S., Clark, L. V., Xu, S., & Cherry, T. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.31.668014 · Cited by 1
Anisimova, I. V., Леонидовна, Д. Е., Konovalov, F. A., & Акимова, И. А. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20181184170-75
Analysis of gene systems across brain disorders
Bach, S. (2021) · Dublin City University Open Access Institutional Repository (Dublin City University)
Metadata
- Authors
- Paciorkowski, A. R., Traylor, R. N., Rosenfeld, J. A., Hoover, J. M., Harris, C. J., Winter, S., Lacassie, Y., Bialer, M., Lamb, A. N., Schultz, R. A., Berry-Kravis, E., Porter, B. E., Falk, M., Venkat, A., Vanzo, R. J., Cohen, J. S., Fatemi, A., Dobyns, W. B., Shaffer, L. G., Ballif, B. C., & Marsh, E. D.
- Affiliations
- University of Rochester Medicine (US)
- PerkinElmer (United States) (US)
- University of Pittsburgh (US)
- University of Missouri (US)
- Children's Hospital Central California (US)
- Children's Hospital of New Orleans (US)
- Northwell Health (US)
- University of Utah (US)
- Stanford University (US)
- Children's Hospital of Philadelphia (US)
- Kennedy Krieger Institute (US)
- University of Washington (US)
- Corresponding author
- Paciorkowski, Alex R.
- ORCID
- Venue
- neurogenetics
- Published
- 2013-02-07
- Volume
- 14
- Issue
- 2
- Pages
- 99-111
- ISSN
- 1364-6745 (ISSN-L)
- 1364-6753
- PMC
- PMC3773516
- OpenAlex
- W2140057847
- Cited by
- 109
- References
- 39
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 9 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 10 · 2015: 11 · 2014: 7
- FWCI
- 6.19
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurogenetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- ARUP Laboratories
- Medical Center, University of Rochester
- National Institute of Neurological Disorders and Stroke (K08NS078054, K02NS065975, R01NS058721)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- hyperkinesia, epilepsy, intellectual disability, autism spectrum disorder, abnormal movements, infantile spasms, myoclonic seizures, forebrain development, GABAergic interneurons, ARX, FMR1 gene, MeCP2, Tbr1, neurodevelopmental disorders
- MeSH terms
- Adolescent, Adult, Animals, Child, Developmental Disabilities, Child, Preschool, Epilepsy, Female, Humans, Hyperkinesis, Infant, Interneurons, Male, Mice, Inbred C57BL, Middle Aged, Nerve Net, Phenotype, Gene Deletion, Mice, Young Adult, Haploinsufficiency, MEF2 Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review